The clinical course and prognosis factors of stomach cancer patients with metastases in the ovaries
https://doi.org/10.17650/1994-4098-2016-12-4-57-62
Abstract
We analyzed the data of 53 patients with metastatic gastric cancer in ovaries treated in the N.N. Blokhin Russian Cancer Research Center in 2009–2014. These patients are the main group. The control group consisted of 55 patients stage III–IV locally advanced gastric cancer without metastases in the ovaries treated with surgical and combined treatment in the period from 2009 to 2014. The main group and control group were matched by major demographic and clinical characteristics. It was found that gastric cancer patients stage III–IV are prognostically unfavorable group. More than half of patients (51 %) with disseminated cancer of the stomach simultaneously diagnosed metastatic ovarian failure. When studying the remote indicators, it is evident that the presence of metastases in the ovaries is significant unfavorable prognostic factor of 2 years overall survival of postmenopausal patients over 50 years old who received only surgical treatment. However, carrying out combined treatment of patients with metastases to the ovary, without significant impairment in the first year of observation, significantly increases the 3–5-year survival (68 %).
About the Authors
S. N. Tadzhibov
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Russian Federation
Build. 2, 8 Trubetskaya St., Moscow 119991
Russian Federation
Build. 2, 8 Trubetskaya St., Moscow 119991
S. B. Polikarpova
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Russian Federation
Build. 2, 8 Trubetskaya St., Moscow 119991
Russian Federation
Build. 2, 8 Trubetskaya St., Moscow 119991
T. M. Kochoyan
Research Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
A. S. Ozherel’ev
Research Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
R. A. Kerimov
Research Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
A. I. Berishvili
Research Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
References
1. Давыдов М.И., Аксель Е.М. Злокачественные образования в России и странах СНГ в 2012 году. М.: МИА, 2012. [Davydov M.I., Aksel’ E.M. Malignant tumors in Russia and CIS countries in 2012. Moscow: MIA, 2012. (In Russ.)].
2. Yada-Hashimoto N., Yamamoto T., Kamiura S. et al. Metastatic ovarian tumors: a review of 64 cases. Gynecol Oncol 2013;89(2):314–7. PMID: 12713997.
3. Sokalska A., Timmerman D., Testa A.C. et al. Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses. Ultrasound Obstet Gynecol 2009;34(4):462–70. DOI: 10.1002/uog.6444. PMID: 19685552.
4. Lee S.J., Bae J.H., Lee A.W. et al. Clinical characteristics of metastatic tumors to the ovaries. J Korean Med Sci 2009;24(1):114–9. DOI: 10.3346/jkms.2009.24.1.114. PMID: 19270823.
5. Al-Agha O.M., Nicastri A.D. An in-depth look at Krukenberg tumor: an overview. Arch Pathol Lab Med 2006;130(11):1725–30. DOI: 10.1043/1543-2165(2006)130[1725:AIL AKT]2.0.CO;2. PMID: 17076540.
6. Kondi-Pafiti A., Kairi-Vasilatou E., Iavazzo C. et al. Metastatic neoplasms of the ovaries: a clinicopathological study of 97 cases. Arch Gynecol Obstet 2011;284(5):1283–8. DOI: 10.1007/s00404-011-1847-4. PMID: 21311903.
7. Ayhan A., Guvenal T., Salman M.C. et al. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries. Gynecol Oncol 2005;98(2):235–41. DOI: 10.1016/j.ygyno.2005.05.028. PMID: 15982725.
8. Alvarado-Cabrero I., Rodríguez-Gómez A., Castelan-Pedraza J., Valencia-Cedillo R. Metastatic ovarian tumors: a clinicopathologic study of 150 cases. Anal Quant Cytopathol Histpathol 2013;35(5):241–8. PMID: 24282903.
9. de Waal Y.R., Thomas C.M., Oei A.L. et al. Secondary ovarian malignancies: frequency, origin, and characteristics. Int J Gynecol Cancer 2009;19(7):1160–5. DOI: 10.1111/IGC.0b013e3181b33cce. PMID: 19823050.
10. Антошечкина Е.Т. Особенности клиники и факторы прогноза при злокачественных опухолях яичников у женщин молодого возраста. В кн.: Диагностика и лечебная тактика при ранних формах злокачественных опухолей яичников. М., 1984. С. 121–4. [Antoshechkina E.T. Clinical features and prognostic factors in malignant ovarian tumors in young women. In: Diagnostics and treatment strategy in early-stage malignant ovarian tumors. Moscow, 1984. Pp. 121–4. (In Russ.)].
11. Кочоян Т.М. Эндохирургия в диагностике и лечении больных с опухолями органов грудной клетки, брюшной полости и забрюшинного пространства. Дис. … д-ра мед. наук. М., 2011. [Kochoyan T.M. Endosurgery in diagnostics and treatment of patients with tumors of chest organs, abdominal cavity, and retroperitoneal space. Thesis ... of doctor of medicine. Moscow, 2011. (In Russ.)].
12. Guerriero S., Alcazar J.L., Pascual M.A. et al. Preoperative diagnosis of metastatic ovarian cancer is related to origin of primary tumor. Ultrasound Obstet Gynecol 2012;39(5):581–6. DOI: 10.1002/uog.10120. PMID: 21998039.
13. Li W., Wang H., Wang J. et al. Ovarian metastases resection from extragenital primary sites: outcome and prognostic factor analysis of 147 patients. BMC Cancer 2012;12:278. DOI: 10.1186/1471-2407-12-278.PMID: 22759383.
14. Peng W., Hua R.X., Jiang R. et al. Surgical treatment for patients with Krukenberg tumor of stomach origin: clinical outcome and prognostic factors analysis. PLoS One 2013;8(7):e68227. DOI: 10.1371/journal.pone.0068227. PMID: 23874550.
Review
For citations:
Tadzhibov S.N., Polikarpova S.B., Kochoyan T.M., Ozherel’ev A.S., Kerimov R.A., Berishvili A.I. The clinical course and prognosis factors of stomach cancer patients with metastases in the ovaries. Tumors of female reproductive system. 2016;12(4):57-62. (In Russ.) https://doi.org/10.17650/1994-4098-2016-12-4-57-62
Views:
3734
Email this article 